Vera Therapeutics Appoints New CMO, Adds Director
Ticker: VERA · Form: 8-K · Filed: Jun 12, 2024 · CIK: 1831828
| Field | Detail |
|---|---|
| Company | Vera Therapeutics, INC. (VERA) |
| Form Type | 8-K |
| Filed Date | Jun 12, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $40,000, $4,000, $400,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-appointment, personnel
TL;DR
Vera Therapeutics beefs up leadership with new CMO and board member to push immune disease drugs.
AI Summary
Vera Therapeutics, Inc. announced on June 7, 2024, the appointment of Dr. Michael W. Gray as Chief Medical Officer and the election of Dr. Laura J. Shaw to its Board of Directors. Dr. Gray brings extensive experience in immunology and clinical development, while Dr. Shaw has a strong background in drug development and regulatory affairs. These appointments are part of the company's ongoing efforts to advance its pipeline of treatments for immune-mediated diseases.
Why It Matters
The appointment of a new Chief Medical Officer and a new board member with relevant expertise signals Vera Therapeutics' commitment to strengthening its leadership and advancing its drug development programs.
Risk Assessment
Risk Level: medium — Changes in key leadership roles can introduce uncertainty, but the addition of experienced professionals may also de-risk future development.
Key Players & Entities
- Vera Therapeutics, Inc. (company) — Registrant
- Dr. Michael W. Gray (person) — Appointed Chief Medical Officer
- Dr. Laura J. Shaw (person) — Elected to Board of Directors
- June 7, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer of Vera Therapeutics?
Dr. Michael W. Gray has been appointed as the new Chief Medical Officer of Vera Therapeutics.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 7, 2024.
Who was elected to the Board of Directors of Vera Therapeutics?
Dr. Laura J. Shaw was elected to the Board of Directors of Vera Therapeutics.
What is the principal executive office address for Vera Therapeutics?
The address of Vera Therapeutics' principal executive offices is 8000 Marina Boulevard, Suite 120, Brisbane, California, 94005.
What is the telephone number for Vera Therapeutics?
The telephone number for Vera Therapeutics is (650) 770-0077.
Filing Stats: 853 words · 3 min read · ~3 pages · Grade level 10.8 · Accepted 2024-06-12 16:05:56
Key Financial Figures
- $0.001 — which registered Class A common stock, $0.001 par value per share VERA The Nasdaq
- $40,000 — also receive an annual cash retainer of $40,000 for her service as on the Board, and $4
- $4,000 — 00 for her service as on the Board, and $4,000 for her service on the Nominating Commi
- $400,000 — grant date fair value of not more than $400,000, subject to her continuous service as o
Filing Documents
- d843919d8k.htm (8-K) — 25KB
- 0001193125-24-159935.txt ( ) — 148KB
- vera-20240607.xsd (EX-101.SCH) — 3KB
- vera-20240607_lab.xml (EX-101.LAB) — 18KB
- vera-20240607_pre.xml (EX-101.PRE) — 11KB
- d843919d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Vera Therapeutics, Inc. Dated: June 12, 2024 By: /s/ Marshall Fordyce, M.D. Marshall Fordyce, M.D. Chief Executive Officer